AAAAAA

   
Results: 1-11 |
Results: 11
Prognostic factors of combined viral load and CD4(+) cell count responses under triple antiretroviral therapy, aquitaine cohort, 1996-1998
Authors: Marimoutou, C Chene, G Mercie, P Neau, D Farbos, S Morlat, P Ceccaldi, J Dabis, F
Citation: C. Marimoutou et al., Prognostic factors of combined viral load and CD4(+) cell count responses under triple antiretroviral therapy, aquitaine cohort, 1996-1998, J ACQ IMM D, 27(2), 2001, pp. 161-167
Trends in causes of death in the Aquitaine cohort of HIV-infected patients, 1995-1997
Authors: Vandentorren, S Mercie, P Marimoutou, C Neau, D Malvy, D Farbos, S Dabis, F
Citation: S. Vandentorren et al., Trends in causes of death in the Aquitaine cohort of HIV-infected patients, 1995-1997, EUR J EPID, 17(1), 2001, pp. 7-10
Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts
Authors: Yazdanpanah, Y Chene, G Losino, E Goldie, SJ Merchadou, LD Alfandari, S Seage, GR Sullivan, L Marimoutou, C Paltiel, AD Salamon, R Mouton, Y Freedberg, KA
Citation: Y. Yazdanpanah et al., Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts, INT J EPID, 30(4), 2001, pp. 864-871
Dual nucleoside regimens in nonadvanced HIV infection: Prospective follow-up of 130 patients, Aquitaine Cohort, 1996 to 1998
Authors: Morlat, P Marimoutou, C Dequae-Merchadou, L Pellegrin, I Mercie, I Neau, D Beylot, J Dabis, F
Citation: P. Morlat et al., Dual nucleoside regimens in nonadvanced HIV infection: Prospective follow-up of 130 patients, Aquitaine Cohort, 1996 to 1998, J ACQ IMM D, 23(3), 2000, pp. 255-260
Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine cohort, France, 1999
Authors: Thiebaut, R Daucourt, V Mercie, P Ekouevi, KD Malvy, D Morlat, P Dupon, M Neau, D Farbos, S Marimoutou, C Dabis, F
Citation: R. Thiebaut et al., Lipodystrophy, metabolic disorders, and human immunodeficiency virus infection: Aquitaine cohort, France, 1999, CLIN INF D, 31(6), 2000, pp. 1482-1487
Effect of ignoring the time of HIV seroconversion in estimating changes insurvival over calendar time in observational studies: results from CASCADE
Authors: Porter, K Babiker, A Walker, S Darbyshire, J Gill, N Beral, V Coutinho, R Darbyshire, J Gill, N Lee, C Meyer, L Rezza, G Porter, K Babiker, A Walker, S Darbyshire, J Tyrer, F Dabis, F Marimoutou, C Meyer, L Boufassa, F Hamouda, O Brunn, M Pezzotti, P Rezza, G Lorenzo, JI Touloumi, G Hatzakis, A Karafoulidou, A Katsarou, O Brettle, R Del Amo, J del Romero, J Prins, M Coutinho, RA van Benthem, B Coutinho, RA Kirk, O Pedersen, C AGuado, IH Perez-Hoyos, S Eskild, A Bruun, JN Sannes, M Sabin, C Lee, C Johnson, AM Phillips, AN Babiker, A Darbyshire, JH Gill, N Porter, K Egger, M Francioli, P Rickenbach, M Cooper, D Kaldor, J Cooper, D Kaldor, J Vizzard, J Tusell, JM Ruiz, I Cayla, JA de Olalla, PG Day, NE De Angelis, D
Citation: K. Porter et al., Effect of ignoring the time of HIV seroconversion in estimating changes insurvival over calendar time in observational studies: results from CASCADE, AIDS, 14(13), 2000, pp. 1899-1906
Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis
Authors: Babiker, A Darby, S De Angelis, D Kwart, D Porter, K Beral, V Darbyshire, J Day, N Gill, N Coutinho, R Prins, M van Benthem, B Coutinho, R Dabis, F Marimoutou, C Ruiz, I Tusell, J Altisent, C Evatt, B Jaffe, H Kirk, O Pedersen, C Rosenberg, P Goedert, J Biggar, R Melbye, M Brettie, R Downs, A Hamouda, O Touloumi, G Karafoulidou, A Katsarou, O Donfield, S Gomperts, E Hilgartner, M Hoots, K Schoenbaum, E Beral, V Zangerle, R Del Amo, J Pezzotti, P Rezza, G Hutchinson, S Day, N De Angelis, D Gore, S Kingsley, L Schrager, L Rosenberg, P Goedert, J Melnick, S Koblin, B Eskild, A Bruun, J Sannes, M Evans, B Lepri, AC Sabin, C Buchbinder, S Vittinghoff, E Moss, A Osmond, D Winkelstein, W Goldberg, D Boufassa, F Meyer, L Egger, M Francioli, P Rickenbach, M Cooper, D Tindall, B Sharkey, T Vizzard, J Kaldor, J Cunningham, P Vanhems, P Vizzard, J Kaldor, J Learmont, J Farewell, V Berglund, O Mosley, J Operskalski, E van den Berg, M Metzger, D Tobin, D Woody, G Rusnak, J Hendrix, C Garner, R Hawkes, C Renzullo, P Garland, F Darby, S Ewart, D Giangrande, P Lee, C Phillips, A Spooner, R Wilde, J Winter, M Babiker, A Darbyshire, J Evans, B Gill, N Johnson, A Phillips, A Porter, K Lorenzo, JI Schechter, M
Citation: A. Babiker et al., Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis, LANCET, 355(9210), 2000, pp. 1131-1137
Prognostic factors after non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus - Aquitaine Cohort, France, 1986-1997
Authors: Thiessard, F Morlat, P Marimoutou, C Labouyrie, E Ragnaud, JM Pellegrin, JL Dupon, M Dabis, F
Citation: F. Thiessard et al., Prognostic factors after non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus - Aquitaine Cohort, France, 1986-1997, CANCER, 88(7), 2000, pp. 1696-1702
Severe hepatic cytolysis: incidence and risk factors in patients treated by antiretroviral combinations Aquitaine Cohort, France, 1996-1998
Authors: Saves, M Vandentorren, S Daucourt, V Marimoutou, C Dupon, M Couzigou, P Bernard, N Mercie, P Dabis, F
Citation: M. Saves et al., Severe hepatic cytolysis: incidence and risk factors in patients treated by antiretroviral combinations Aquitaine Cohort, France, 1996-1998, AIDS, 13(17), 1999, pp. F115-F121
Incidence of acquired immunodeficiency syndrome (AIDS)-related Kaposi's sarcoma in the Aquitaine Cohort, France, 1988-1996
Authors: Dupon, M Marimoutou, C Cazorla, C Binquet, C Chene, G Pellegrin, JL Dutronc, H Nouts, C Dabis, F
Citation: M. Dupon et al., Incidence of acquired immunodeficiency syndrome (AIDS)-related Kaposi's sarcoma in the Aquitaine Cohort, France, 1988-1996, INT J EPID, 27(6), 1998, pp. 1078-1082
Survival of HIV-infected patients with cytomegalovirus retinitis under highly active antiretroviral therapy
Authors: Binquet, C Saillour, F Bernard, N Marimoutou, C Dabis, F
Citation: C. Binquet et al., Survival of HIV-infected patients with cytomegalovirus retinitis under highly active antiretroviral therapy, AIDS, 12(18), 1998, pp. 2502-2504
Risultati: 1-11 |